The largest database of trusted experimental protocols

5 protocols using cd38 brilliant violet 421

1

Multiparametric Flow Cytometry Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stained for 30 min on ice with the following mouse anti-human antibodies: CD3-BrilliantViolet421, CD4-AlexaFluor700, CD8β-PE, CD31-FITC, CD34-PE, CD45RA-PE/CF594, TCRgd-FITC (BD Biosciences), CD5-PE/Cy7, CD7-AlexaFluor700, CD45-APC/eFluor780, TCRab-APC (eBiosciences), CD8α-PE/Dazzle, CD38-BrilliantViolet421 (BioLegend). Cells were resuspended in flow cytometry buffer containing DAPI, data was collected using LSR Fortessa flow cytometer (BD Biosciences) and analyzed using FlowJo version 9.7.6. For intracellular staining, cells were fixed and permeabilized using Fixation/Permeabilization kit with GolgiPlug (BD Biosciences) as per manufacturer’s instructions.
+ Open protocol
+ Expand
2

Quantifying Immune Activation Markers in HIV

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sera samples of immunological responders and non-responders were collected to measure the bacterial translocation markers. Following the standard protocols, human Lipopolysaccharides (LPS) ELISA Kit (CUSABIO; Wuhan, China) and Human soluble CD14 (sCD14) ELISA Kit (MultiSciences, Hangzhou, China) were used to test plasma LPS and sCD14. Flow cytometry and Cobas Amplicor (Roche Molecular Systems Inc., Branchburg, New Jersey, United States) were used to quantify CD4 + /CD8 + T-cells and HIV-1 RNA, respectively. Fresh anticoagulated whole blood was used to quantify the expressing markers of immune activation (CD25 +, CD38 +, HLADR +, or CD38 + /HLA-DR +) of CD4 + and CD8 + T-cells and immune senescence (CD57 +) by BD FACS Canto II flow cytometer (BD Biosciences, California, United States). The antibodies needed during the experiment were purchased from Biolegend (San Diego, CA), including CD3-FITC, CD4- PerCP/Cy5.5, CD8-Brilliant Violet 510™, CD38-Brilliant Violet 421, CD25-PE, HLA-DR-APC/Fire™ 750, and CD57-allophycocyanin (APC).
+ Open protocol
+ Expand
3

Quantification of T-cell Markers in HIV

Check if the same lab product or an alternative is used in the 5 most similar protocols
Quantifications of CD4+ and CD8+ T-cells as well as HIV-1 RNA were carried out in HIV-infected individuals using flow cytometry and Cobas Amplicor (Roche Molecular Systems Inc., Branchburg, New Jersey, USA) as the clinical routine. The percentage of CD4+ and CD8+ T cells expressing markers of activation (CD25+, CD38+, HLADR+, or CD38+/HLA-DR+) and senescence (CD57+) were quantified by the BD FACS Canto II flow cytometer (BD Biosciences, California, USA) using fresh anticoagulated whole blood. Antibody such as CD3-FITC, CD4- PerCP/Cy5.5, CD8-Brilliant Violet 510™, CD38-Brilliant Violet 421, CD25-PE, HLA-DR-APC/Fire™ 750, and CD57-allophycocyanin (APC) were purchased from Biolegend (San Diego, CA).
+ Open protocol
+ Expand
4

Immunophenotyping of HIV Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Quanti cations of and CD8+ as well as HIV-1 RNA were carried out in HIV-infected individuals using ow cytometry and Cobas Amplicor (Roche Molecular Systems Inc., Branchburg, New Jersey, USA) as the clinical routine. The percentage of CD4+ and CD8+ T cells expressing markers of activation (CD25+, CD38+, HLADR+, or CD38+/HLA-DR+) and senescence (CD57+) were quanti ed by the BD FACS Canto II ow cytometer (BD Biosciences, California, USA) using fresh anticoagulated whole blood. Antibody such as CD3-FITC, CD4-PerCP/Cy5.5, CD8-Brilliant Violet 510™, CD38-Brilliant Violet 421, CD25-PE, HLA-DR-APC/Fire™ 750, and CD57-allophycocyanin (APC) were purchased from Biolegend (San Diego, CA).
+ Open protocol
+ Expand
5

Quantification of T-cell Subsets in HIV

Check if the same lab product or an alternative is used in the 5 most similar protocols
Quanti cations of CD4+ and CD8+ T-cells as well as HIV-1 RNA were carried out in HIV-infected individuals using ow cytometry and Cobas Amplicor (Roche Molecular Systems Inc., Branchburg, New Jersey, USA) as the clinical routine. The percentage of CD4+ and CD8+ T cells expressing markers of activation (CD25+, CD38+, HLADR+, or CD38+/HLA-DR+) and senescence (CD57+) were quanti ed by the BD FACS Canto II ow cytometer (BD Biosciences, California, USA) using fresh anticoagulated whole blood. Antibody such as CD3-FITC, CD4-PerCP/Cy5.5, CD8-Brilliant Violet 510™, CD38-Brilliant Violet 421, CD25-PE, HLA-DR-APC/Fire™ 750, and CD57-allophycocyanin (APC) were purchased from Biolegend (San Diego, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!